Your selections:
- Hart, Matthew E., Chamberlin, A. Richard, Walkom, Cecilia, Sakoff, Jennette A., McCluskey, Adam
- Sakoff, Jennette A., Howitt, Ian J., Ackland, Stephen P., McCluskey, Adam
Mast cell function: regulation of degranulation by serine/threonine phosphatases
- Sim, Alistair T. R., Ludowyke, Russell I., Verrills, Nicole M.
- Hill, Timothy A., Stewart, Scott G., Sauer, Benjamin, Gilbert, Jayne, Ackland, Stephen P., Sakoff, Jennette A., McCluskey, Adam
Synthesis and biological evaluation of norcantharidin analogues: towards PP1 selectivity
- Stewart, Scott G., Hill, Timothy A., Gilbert, Jayne, Ackland, Stephen P., Sakoff, Jennette A., McCluskey, Adam
- Kranias, Gregory, Watt, Lauren F., Carpenter, Helen, Holst, Jeff, Ludowyke, Russell, Strack, Stefan, Sim, Alistair T. R., Verrills, Nicole M.
Regulation of the tumour suppressor PP2A by oncogenic tyrosine kinases
PP2A phosphatase suppresses function of the mesenchymal invasion regulator NEDD9
- Bradbury, Peta, Mahmassani, Maha, Zhong, Jessie, Turner, Kylie, Paul, Andre, Verrills, Nicole M., O'Neill, Geraldine M.
Suppression of PP2A is critical for protection of melanoma cells upon endoplasmic reticulum stress
- Tay, K. H., Jin, L., Zhang, X. D., Tseng, H. - Y., Jiang, C. C., Ye, Y., Thorne, R. F., Liu, T., Guo, S. T., Verrills, N. M., Hersey, P.
The role of Protein Phosphatase 2A as a tumour suppressor in breast cancer
- Sontag, Jean-Marie, Nunbhakdi-Craig, Viyada, Sontag, Estelle
Altered protein phosphatase 2A methylation and Tau phosphorylation in the young and aged brain of methylenetetrahydrofolate reductase (MTHFR) deficient mice
- Sontag, Jean-Marie, Wasek, Brandi, Taleski, Goce, Smith, Josephine, Arning, Erland, Sontag, Estelle, Bottiglieri, T
Targeting PP2A activation as a novel therapeutic strategy for receptor tyrosine kinase driven leukaemia
Basal protein phosphatase 2A activity restrains cytokine expression: role for MAPKs and tristetraprolin
- Rahman, Md. Mostafizur, Rumzhum, Nowshin N., Morris, Jonathan C., Clark, Andrew R., Verrills, Nicole M., Ammit, Alaina J.
Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors
- Smith, Amanda M., Dun, Matthew D., Toop, Hamish, Lock, Richard B., Powell, Jason A., Thomas, Daniel, Guthridge, Mark A., Moore, Andrew, Ashman, Leonie K., Skelding, Kathryn A., Enjeti, Anoop, Verrills, Nicole M., Lee, Erwin M., Harrison, Celeste, Kahl, Richard, Flanagan, Hayley, Panicker, Nikita, Mashkani, Baratali, Don, Anthony S., Morris, Jonathan
Immunoregulatory therapies for inflammatory diseases
- Rahman, Md. Mostafizur, Prabhala, Pavan, Rumzhum, Nowshin N., Patel, Brijeshkumar S., Wickop, Thomas, Hansbro, Phillip M., Verrills, Nicole M., Ammit, Alaina J.
- Sokulsky, Leon A., Collison, Adam M., Nightingale, Scott, Le Fevre, Anna, Percival, Elizabeth, Starkey, Malcolm R., Hansbro, Philip M., Foster, Paul S., Mattes, Joerg
Functional importance of PP2A regulatory subunit loss in breast cancer
- Watt, Lauren F., Panicker, Nikita, Mannan, Abdul, Copeland, Ben, Kahl, Richard G. S., Dun, Matthew D., Young, Barbara, Roselli, Severine, Verrills, Nicole M.
- Hoffman, Alexander, Taleski, Goce, Sontag, Estelle
Are you sure you would like to clear your session, including search history and login status?